These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 23069279)

  • 1. KIT gene exon 11 mutations in canine malignant melanoma.
    Chu PY; Pan SL; Liu CH; Lee J; Yeh LS; Liao AT
    Vet J; 2013 May; 196(2):226-30. PubMed ID: 23069279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of KIT expression and KIT exon 11 mutations in canine oral malignant melanomas.
    Murakami A; Mori T; Sakai H; Murakami M; Yanai T; Hoshino Y; Maruo K
    Vet Comp Oncol; 2011 Sep; 9(3):219-24. PubMed ID: 21848624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Canine subcutaneous mast cell tumors: cellular proliferation and KIT expression as prognostic indices.
    Thompson JJ; Yager JA; Best SJ; Pearl DL; Coomber BL; Torres RN; Kiupel M; Foster RA
    Vet Pathol; 2011 Jan; 48(1):169-81. PubMed ID: 21160022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human malignant melanoma: detection of BRAF- and c-kit-activating mutations by high-resolution amplicon melting analysis.
    Willmore-Payne C; Holden JA; Tripp S; Layfield LJ
    Hum Pathol; 2005 May; 36(5):486-93. PubMed ID: 15948115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-kit expression in canine mucosal melanomas.
    Newman SJ; Jankovsky JM; Rohrbach BW; LeBlanc AK
    Vet Pathol; 2012 Sep; 49(5):760-5. PubMed ID: 21825314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-Kit SCF receptor (CD117) expression and KIT gene mutation in conjunctival pigmented lesions.
    Alessandrini L; Parrozzani R; Bertorelle R; Valentini E; Candiotto C; Giacomelli L; Midena E; Blandamura S
    Acta Ophthalmol; 2013 Dec; 91(8):e641-5. PubMed ID: 23742652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of tyrosine-kinase receptor c-kit mutations, mRNA and protein expression in canine lymphoma: might c-kit represent a therapeutic target?
    Giantin M; Aresu L; Aricò A; Gelain ME; Riondato F; Comazzi S; Dacasto M
    Vet Immunol Immunopathol; 2013 Aug; 154(3-4):153-9. PubMed ID: 23791075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of tyrosine-kinase receptor c-KIT (c-KIT) mutations, mRNA and protein expression in canine leukemia: might c-KIT represent a therapeutic target?
    Giantin M; Aresu L; Aricò A; Gelain ME; Riondato F; Martini V; Comazzi S; Dacasto M
    Vet Immunol Immunopathol; 2013 Apr; 152(3-4):325-32. PubMed ID: 23375718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L576P KIT mutation in anal melanomas correlates with KIT protein expression and is sensitive to specific kinase inhibition.
    Antonescu CR; Busam KJ; Francone TD; Wong GC; Guo T; Agaram NP; Besmer P; Jungbluth A; Gimbel M; Chen CT; Veach D; Clarkson BD; Paty PB; Weiser MR
    Int J Cancer; 2007 Jul; 121(2):257-64. PubMed ID: 17372901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-kit gene mutation and CD117 expression in human anorectal melanomas.
    Ni S; Huang D; Chen X; Huang J; Kong Y; Xu Y; Du X; Sheng W
    Hum Pathol; 2012 Jun; 43(6):801-7. PubMed ID: 22154054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BRAF and c-kit gene copy number in mutation-positive malignant melanoma.
    Willmore-Payne C; Holden JA; Hirschowitz S; Layfield LJ
    Hum Pathol; 2006 May; 37(5):520-7. PubMed ID: 16647948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COX-2 and c-kit expression in canine gliomas.
    Jankovsky JM; Newkirk KM; Ilha MR; Newman SJ
    Vet Comp Oncol; 2013 Mar; 11(1):63-9. PubMed ID: 22235799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of c-kit mutations-independent neoplastic cell proliferation of canine mast cells.
    Ohmori K; Kawarai S; Yasuda N; Tanaka A; Matsuda H; Nishimura R; Sasaki N; Tsujimoto H; Masuda K
    Vet Immunol Immunopathol; 2008 Nov; 126(1-2):43-53. PubMed ID: 18687474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KIT polymorphisms and mutations determine responses of neoplastic mast cells to bafetinib (INNO-406).
    Peter B; Hadzijusufovic E; Blatt K; Gleixner KV; Pickl WF; Thaiwong T; Yuzbasiyan-Gurkan V; Willmann M; Valent P
    Exp Hematol; 2010 Sep; 38(9):782-91. PubMed ID: 20685234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KIT pathway alterations in mucosal melanomas of the vulva and other sites.
    Omholt K; Grafström E; Kanter-Lewensohn L; Hansson J; Ragnarsson-Olding BK
    Clin Cancer Res; 2011 Jun; 17(12):3933-42. PubMed ID: 21680547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of GIST/GIPACT tumors by inmunohistochemistry and exon 11 analysis of c-kit by PCR.
    Bernet L; Zuñiga A; Cano R
    Rev Esp Enferm Dig; 2003 Oct; 95(10):688-91, 683-7. PubMed ID: 14588063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation Between KIT Expression and
    Smedley RC; Thaiwong T; Deeth LE; Kiupel M
    Vet Pathol; 2021 Jul; 58(4):683-691. PubMed ID: 33910439
    [No Abstract]   [Full Text] [Related]  

  • 18. Analysis of KIT expression and gene mutation in human acral melanoma: with a comparison between primary tumors and corresponding metastases/recurrences.
    Dai B; Cai X; Kong YY; Yang F; Shen XX; Wang LW; Kong JC
    Hum Pathol; 2013 Aug; 44(8):1472-8. PubMed ID: 23528861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein expression of KIT and gene mutation of c-kit and PDGFRs in Ewing sarcomas.
    Do I; Araujo ES; Kalil RK; Bacchini P; Bertoni F; Unni KK; Park YK
    Pathol Res Pract; 2007; 203(3):127-34. PubMed ID: 17298867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RAS, FLT3, and C-KIT mutations in immunophenotyped canine leukemias.
    Usher SG; Radford AD; Villiers EJ; Blackwood L
    Exp Hematol; 2009 Jan; 37(1):65-77. PubMed ID: 18977066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.